| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $1,517,703 ) |
| | 2025 | 2025 | SINOPIA BIOSCIENCES INC | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R43GM157800 | Development of neural network models to enable efficient metabolomic characterization of compound libraries for data-driven drug discovery | 000 | 1 | NIH | 7/23/2025 | $350,000 |
| | 2025 | 2025 | SINOPIA BIOSCIENCES INC | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R44DE031464 | Preclinical assessment of a novel compound for treating radiation-induced oral mucositis | 001 | 3 | NIH | 8/15/2025 | $39,650 |
| | 2025 | 2025 | SINOPIA BIOSCIENCES INC | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R44DE031464 | Preclinical assessment of a novel compound for treating radiation-induced oral mucositis | 000 | 3 | NIH | 8/4/2025 | $849,193 |
| | 2025 | 2025 | SINOPIA BIOSCIENCES INC | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R43CA295316 | Development of a metabolomics enabled AI/ML platform for discovery of new treatments to enhance drug sensitivity in cancer | 000 | 1 | NIH | 9/18/2025 | $285,599 |
| | 2025 | 2024 | SINOPIA BIOSCIENCES INC | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R44NS124398 | Preclinical development of a novel therapeutic for Parkinson's disease | 001 | 3 | NIH | 8/14/2025 | $0 |
| | 2025 | 2024 | SINOPIA BIOSCIENCES INC | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R44NS124398 | Preclinical development of a novel therapeutic for Parkinson's disease | 000 | 3 | NIH | 5/29/2025 | $0 |
| | 2025 | 2024 | SINOPIA BIOSCIENCES INC | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R43GM154585 | Development and validation of data standards and computational methods for large scale metabolomics data analysis for data driven drug discovery | 000 | 1 | NIH | 8/5/2025 | -$6,739 |
| | 2025 | 2022 | SINOPIA BIOSCIENCES INC | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R43DE031464 | Preclinical assessment of a novel compound for treating radiation-induced oral mucositis | 000 | 1 | NIH | 5/7/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $3,125,934 ) |
| | 2024 | 2024 | SINOPIA BIOSCIENCES INC | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R44NS124398 | Preclinical development of a novel therapeutic for Parkinson's disease | 000 | 3 | NIH | 3/1/2024 | $1,282,299 |
| | 2024 | 2024 | SINOPIA BIOSCIENCES INC | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R43GM154585 | Development and validation of data standards and computational methods for large scale metabolomics data analysis for data driven drug discovery | 000 | 1 | NIH | 4/18/2024 | $350,000 |
| | 2024 | 2024 | SINOPIA BIOSCIENCES INC | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R44DE031464 | Preclinical assessment of a novel compound for treating radiation-induced oral mucositis | 001 | 2 | NIH | 9/25/2024 | $174,104 |
| | 2024 | 2024 | SINOPIA BIOSCIENCES INC | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R44DE031464 | Preclinical assessment of a novel compound for treating radiation-induced oral mucositis | 000 | 2 | NIH | 9/4/2024 | $1,319,531 |
| | 2024 | 2022 | SINOPIA BIOSCIENCES INC | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R43DE031464 | Preclinical assessment of a novel compound for treating radiation-induced oral mucositis | 000 | 1 | NIH | 8/29/2024 | $0 |
| | 2024 | 2022 | SINOPIA BIOSCIENCES INC | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R44GM130268 | Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery | 000 | 3 | NIH | 6/25/2024 | $0 |
| | 2024 | 2021 | SINOPIA BIOSCIENCES INC | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R44NS124398 | Preclinical development of a novel therapeutic for Parkinson's disease | 001 | 1 | NIH | 9/10/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,561,760 ) |
| | 2023 | 2023 | SINOPIA BIOSCIENCES INC | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R44NS124398 | Preclinical development of a novel therapeutic for Parkinson's disease | 002 | 2 | NIH | 8/30/2023 | $99,900 |
| | 2023 | 2023 | SINOPIA BIOSCIENCES, INC. | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R44NS124398 | Preclinical development of a novel therapeutic for Parkinson's disease | 001 | 2 | NIH | 3/20/2023 | $1,461,860 |
| | 2023 | 2021 | SINOPIA BIOSCIENCES, INC. | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R44NS124398 | Preclinical development of a novel therapeutic for Parkinson's disease | 000 | 1 | NIH | 3/17/2023 | $0 |
| | 2023 | 2020 | SINOPIA BIOSCIENCES INC | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R44GM121117 | Developing a systems biology platform for predicting, preventing, and treating drug side effects | 000 | 3 | NIH | 10/29/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $1,189,870 ) |
| | 2022 | 2022 | SINOPIA BIOSCIENCES, INC. | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R44GM130268 | Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery | 000 | 3 | NIH | 2/11/2022 | $871,587 |
| | 2022 | 2022 | SINOPIA BIOSCIENCES, INC. | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R43DE031464 | Preclinical assessment of a novel compound for treating radiation-induced oral mucositis | 000 | 1 | NIH | 9/20/2022 | $318,284 |
| | 2022 | 2021 | SINOPIA BIOSCIENCES, INC. | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R44NS124398 | Preclinical development of a novel therapeutic for Parkinson's disease | 000 | 1 | NIH | 12/24/2021 | $0 |
| | 2022 | 2018 | SINOPIA BIOSCIENCES, INC. | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R44HL127843 | Improving safety and efficacy of platelet transfusion through systems biology | 001 | 3 | NIH | 5/18/2022 | -$1 |
| | 2022 | 2018 | SINOPIA BIOSCIENCES, INC. | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R44HL127843 | Improving safety and efficacy of platelet transfusion through systems biology | 000 | 3 | NIH | 10/28/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,913,559 ) |
| | 2021 | 2021 | SINOPIA BIOSCIENCES, INC. | 600 W BROADWAY SUITE 700 | SAN DIEGO | CA | 92101-3370 | SAN DIEGO | USA | R44GM130268 | Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery | 000 | 2 | NIH | 2/5/2021 | $1,335,997 |
| | 2021 | 2021 | SINOPIA BIOSCIENCES, INC. | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R44NS124398 | Preclinical development of a novel therapeutic for Parkinson's disease | 000 | 1 | NIH | 9/17/2021 | $577,562 |
| | 2021 | 2019 | SINOPIA BIOSCIENCES, INC. | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R43HL146014 | Improving safety and efficacy of platelet pathogen inactivation techniques through systems biology | 000 | 1 | NIH | 4/21/2021 | $0 |
| | 2021 | 2018 | SINOPIA BIOSCIENCES, INC. | 3210 MERRYFIELD ROW | SAN DIEGO | CA | 92121-1126 | SAN DIEGO | USA | R43GM130268 | Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery | 000 | 1 | NIH | 5/16/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $754,478 ) |
| | 2020 | 2020 | SINOPIA BIOSCIENCES, INC. | 600 W BROADWAY SUITE 700 | SAN DIEGO | CA | 92101-3370 | SAN DIEGO | USA | R44GM121117 | Developing a systems biology platform for predicting, preventing, and treating drug side effects | 000 | 3 | NIH | 5/1/2020 | $754,478 |
| | 2020 | 2018 | SINOPIA BIOSCIENCES, INC. | 600 W BROADWAY SUITE 700 | SAN DIEGO | CA | 92101-3370 | SAN DIEGO | USA | R44HL127843 | Improving safety and efficacy of platelet transfusion through systems biology | 000 | 3 | NIH | 3/9/2020 | $0 |
| | 2020 | 2017 | SINOPIA BIOSCIENCES, INC. | 600 W BROADWAY SUITE 700 | SAN DIEGO | CA | 92101-3370 | SAN DIEGO | USA | R44HL123074 | Improving red blood cell transfusion through systems biology | 000 | 3 | NIH | 11/14/2019 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $1,026,822 ) |
| | 2019 | 2019 | SINOPIA BIOSCIENCES, INC. | 600 W BROADWAY SUITE 700 | SAN DIEGO | CA | 92101-3370 | SAN DIEGO | USA | R43HL146014 | Improving safety and efficacy of platelet pathogen inactivation techniques through systems biology | 000 | 1 | NIH | 3/5/2019 | $224,284 |
| | 2019 | 2019 | SINOPIA BIOSCIENCES, INC. | 600 W BROADWAY SUITE 700 | SAN DIEGO | CA | 92101-3370 | SAN DIEGO | USA | R44GM121117 | Developing a systems biology platform for predicting, preventing, and treating drug side effects | 000 | 2 | NIH | 4/26/2019 | $802,538 |
|
| Issue Date FY: 2018 ( Subtotal = $871,154 ) |
| | 2018 | 2018 | SINOPIA BIOSCIENCES, INC. | 600 W BROADWAY SUITE 700 | SAN DIEGO | CA | 92101-3370 | SAN DIEGO | USA | R43GM130268 | Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery | 000 | 1 | NIH | 8/29/2018 | $442,427 |
| | 2018 | 2018 | SINOPIA BIOSCIENCES, INC. | 600 W BROADWAY SUITE 700 | SAN DIEGO | CA | 92101-3370 | SAN DIEGO | USA | R44HL127843 | Improving safety and efficacy of platelet transfusion through systems biology | 000 | 3 | NIH | 3/21/2018 | $428,727 |
| | 2018 | 2016 | SINOPIA BIOSCIENCES, INC. | 600 W BROADWAY SUITE 700 | SAN DIEGO | CA | 92101-3370 | SAN DIEGO | USA | R43GM121117 | Developing a Systems Biology Platform for Predicting Drug Toxicity and Safety | 000 | 1 | NIH | 9/16/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $1,542,373 ) |
| | 2017 | 2017 | SINOPIA BIOSCIENCES, INC. | 600 W BROADWAY SUITE 700 | SAN DIEGO | CA | 92101-3370 | SAN DIEGO | USA | R44HL127843 | Improving safety and efficacy of platelet transfusion through systems biology | 000 | 2 | NIH | 6/14/2017 | $1,099,022 |
| | 2017 | 2017 | SINOPIA BIOSCIENCES, INC. | 600 W BROADWAY SUITE 700 | SAN DIEGO | CA | 92101-3370 | SAN DIEGO | USA | R44HL123074 | Improving red blood cell transfusion through systems biology | 000 | 3 | NIH | 5/26/2017 | $443,351 |
|
| Issue Date FY: 2016 ( Subtotal = $1,219,924 ) |
| | 2016 | 2016 | SINOPIA BIOSCIENCES INC | 600 WEST BROADWAY | SAN DIEGO | CA | 92101 | SAN DIEGO | USA | R44HL123074 | Improving red blood cell transfusion through systems biology | 000 | 2 | NIH | 8/15/2016 | $1,029,290 |
| | 2016 | 2016 | SINOPIA BIOSCIENCES INC | 600 WEST BROADWAY | SAN DIEGO | CA | 92101 | SAN DIEGO | USA | R43GM121117 | Developing a Systems Biology Platform for Predicting Drug Toxicity and Safety | 000 | 1 | NIH | 9/13/2016 | $190,634 |
|
|
